Shenzhen Weirun Medical Technology Co., Ltd. – Trademark Portfolio

Entity Type: 99

Shenzhen Weirun Medical Technology Co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include VERAYLIFE. The owner is based in Shenzhen.

Xin'an Street, Baoan District,

4F, Building 2, No. 83, Dabao Road,

Shenzhen 518000 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

VERAYLIFE
VERAYLIFE
Registered 2024

Trademark Classifications

Shenzhen Weirun Medical Technology Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Shenzhen Weirun Medical Technology Co., Ltd. have?

Shenzhen Weirun Medical Technology Co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Shenzhen Weirun Medical Technology Co., Ltd. file in?

Shenzhen Weirun Medical Technology Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Shenzhen Weirun Medical Technology Co., Ltd.'s most well-known trademarks?

Shenzhen Weirun Medical Technology Co., Ltd.'s registered trademark portfolio includes well-known marks such as VERAYLIFE. These are among 1 currently registered trademark in the portfolio.

What is Shenzhen Weirun Medical Technology Co., Ltd.'s trademark registration success rate?

Shenzhen Weirun Medical Technology Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.